Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02189785 · ClinicalTrials.gov registry record
Endogenous Opioid Mechanisms for Rejection Sensitivity
A clinical trial, sponsored by Stony Brook University.
- Completed
- Registry status
- 114
- Enrollment target
NCT02189785 is a clinical trial that has completed, run by Stony Brook University. The registered enrollment target is 114 participants.
The verdict
NCT02189785 has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
Study Summary
This project hypothesizes that the brain's opioid system determines rejection sensitivity, a personality trait that is a vulnerability factor and feature of several psychiatric disorders. This project will use positron emission tomography to measure the brain's opioid response to social rejection and acceptance in a nonclinical population with varying levels of rejection sensitivity. The results will provide the first major step towards understanding a neurotransmitter mechanism for rejection sensitivity, allowing for further investigation into predicting and treating its associated disorders.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-06-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02189785
The ClinicalTrials.gov registry entry for NCT02189785 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02189785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02189785 about?
NCT02189785 is a clinical study titled "Endogenous Opioid Mechanisms for Rejection Sensitivity". This project hypothesizes that the brain's opioid system determines rejection sensitivity, a personality trait that is a vulnerability factor and feature of several psychiatric disorders. This project will use positron emission tomography to measure the brain's opioid response to social rejection an...
What is the current status of trial NCT02189785?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2016-08. Estimated completion is 2019-06-06.
Who is sponsoring clinical trial NCT02189785?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.